Medline Inc 's Cash & cash equivalent grew by 34.78 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Medline Inc 's Quick Ratio to 1.12 a new company high.

Within Medical Equipment & Supplies industry 103 other companies have achieved higher Quick Ratio than Medline Inc in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 2127, from total ranking in the second quarter 2026 at 2759.

Explain Quick Ratio?
How much Cash & cash equivalents MDLN�s has?
What are MDLN�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MDLN Quick Ratio	(Sep 26 2026) Q3	(Jun 27 2026) Q2	(Mar 28 2026) Q1	(Dec 31 2025) Q4	(Dec 31 2024) Q3
Y / Y Current Liabilities Change	27.07 %	-	-	-	-
Y / Y Cash & cash equivalent Change	1713.07 %	-	-	-	-
Quick Ratio MRQ	1.12	0.96	0.88	0.78	0.08
MDLN's Total Ranking	# 2127	# 2759	#	#	#
Seq. Current Liabilities Change	14.56 %	10.53 %	1.85 %	-1.46 %	-
Seq. Cash & cash equivalent Change	34.78 %	19.72 %	15.32 %	874.37 %	-

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 104
Healthcare Sector	# 608
Overall Market	# 1878

Quick Ratio Statistics
High	Average	Low
1.12	0.76	0.08
(Sep 26 2026)		(Dec 31 2024)

Financial Statements
Medline Inc 's Current Liabilities	$ 3,211 Millions	Visit MDLN's Balance sheet
Medline Inc 's Cash & cash equivalent	$ 3,608 Millions	Visit MDLN's Balance sheet
Source of MDLN's Sales		Visit MDLN's Sales by Geography

Cumulative Medline Inc 's Quick Ratio

MDLN's Quick Ratio for the trailling 12 Months

MDLN Quick Ratio	(Sep 26 2026) 12 Months	(Jun 27 2026) 12 Months	(Mar 28 2026) 12 Months	(Dec 31 2025) 12 Months	(Dec 31 2024) 12 Months
Y / Y Current Liabilities TTM Growth	336.88 %	-	-	-	-
Y / Y Cash & cash equivalent TTM Growth	5156.28 %	-	-	-	-
Quick Ratio TTM	0.95	0.68	0.58	0.43	0.08
Total Ranking TTM	# 2127	# 2759	#	#	#
Seq. Current Liabilities TTM Growth	6.6 %	37.11 %	50.55 %	98.54 %	-
Seq. Cash & cash equivalent TTM Growth	48.35 %	61.2 %	104.58 %	974.37 %	-

Quick ratio ranking by company, industry and sector >> Back to MDLN Financial Strength Comparisons >> Go to Compare MDLN Quick Ratio to its Competitors

On the trailing twelve months basis MDLN Cash & cash equivalent more than doubled by 1713.07 % in Q3 2026 year on year, faster than Current Liabilities, this led to increase in in Medline Inc 's Quick Ratio to 0.95, above MDLN average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 103 other companies have achieved higher Quick Ratio than Medline Inc . While overall ranking is unchanged compared to the previous 12 months at no. 0.

Explain Quick Ratio?
How much Cash & cash equivalents MDLN�s has?
What are MDLN�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 104
Healthcare Sector	# 608
Within the Market	# 2127

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.12	0.76	0.08
(Sep 26 2026)		(Dec 31 2024)

Companies with similar Quick Ratio in the quarter ending Sep 26 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Sep 26 2026 MRQ Cash & cash equivalent	Sep 26 2026 MRQ Current Liabilities
Outset Medical Inc	3.07	$ 136.627 Millions	$ 44.453 Millions
Sharps Technology Inc	2.82	$ 7.478 Millions	$ 2.650 Millions
Edwards Lifesciences Corporation	2.81	$ 4,683.700 Millions	$ 1,664.300 Millions
Mimedx Group Inc	2.81	$ 120.791 Millions	$ 43.031 Millions
Pulse Biosciences Inc	2.74	$ 36.725 Millions	$ 13.395 Millions
Staar Surgical Co	2.73	$ 206.414 Millions	$ 75.541 Millions
Medinotec Inc	2.68	$ 2.584 Millions	$ 0.963 Millions
Glaukos Corp	2.66	$ 337.478 Millions	$ 126.726 Millions
Pulmonx Corporation	2.57	$ 53.245 Millions	$ 20.739 Millions
Beta Bionics Inc	2.48	$ 81.551 Millions	$ 32.836 Millions
Irhythm Holdings Inc	2.46	$ 560.719 Millions	$ 228.025 Millions
Apyx Medical Corp	2.37	$ 25.777 Millions	$ 10.870 Millions
Atricure Inc	2.23	$ 187.031 Millions	$ 83.972 Millions
Inspire Medical Systems inc	1.96	$ 190.803 Millions	$ 97.438 Millions
Merit Medical Systems Inc	1.90	$ 503.551 Millions	$ 265.083 Millions
Nephros Inc	1.89	$ 4.546 Millions	$ 2.409 Millions
Warby Parker Inc	1.77	$ 287.914 Millions	$ 162.226 Millions
Anika Therapeutics Inc	1.68	$ 44.957 Millions	$ 26.725 Millions
Intuitive Surgical Inc	1.60	$ 4,042.500 Millions	$ 2,533.000 Millions
Tactile Systems Technology Inc	1.58	$ 75.110 Millions	$ 47.499 Millions
Edap Tms Sa	1.56	$ 56.269 Millions	$ 36.070 Millions
Envista Holdings Corporation	1.42	$ 1,158.800 Millions	$ 816.300 Millions
Si bone inc	1.20	$ 35.460 Millions	$ 29.619 Millions
Medline Inc	1.12	$ 3,608.000 Millions	$ 3,211.000 Millions
Pro dex Inc	1.10	$ 14.219 Millions	$ 12.884 Millions
Penumbra Inc	1.09	$ 254.282 Millions	$ 233.810 Millions
Establishment Labs Holdings Inc	1.06	$ 75.812 Millions	$ 71.611 Millions
Globus Medical Inc	1.02	$ 517.435 Millions	$ 507.938 Millions
Envoy Medical Inc	0.98	$ 14.570 Millions	$ 14.861 Millions
Integra Lifesciences Holdings Corp	0.95	$ 311.930 Millions	$ 329.002 Millions

Date modified: 2026-11-06T13:07:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.